# Limited Competition: Clinical Research Sites (CRS) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/rfa-hl-26-009-limited-competition-clinical-research-sites-crs-for-the/  
Official notice: https://www.grants.gov/search-results-detail/358275

> National Institutes of Health offered grants of up to $2.4 million to colleges and universities. Applications closed on May 2, 2025.

| Field | Value |
|---|---|
| Opportunity number | RFA-HL-26-009 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | May 2, 2025 |
| Award ceiling | $2.4 million |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.121, 93.173, 93.233, 93.242, 93.273, 93.279, 93.307, 93.313, 93.361, 93.393, 93.837, 93.838, 93.839, 93.840, 93.855, 93.865, 93.866 |

## Who can apply

- Public and State controlled institutions of higher education
- Private institutions of higher education

Other Eligible Applicants include the following: See NOFO for further eligibility criteria. Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

## What the grant funds

The purpose of this Notice of Funding Opportunity (NOFO) is to renew the MACS/WIHS Combined Cohort Study of HIV in United States Adults (MWCCS) for a 6-year project period (2026-2032). Continuation of this epidemiological cohort study of middle-aged and older people living with HIV (PLWH), along with comparable people living without HIV (PLWOH) will enable the continued follow-up of a deeply phenotyped cohort of more than 5,600 participants from across the United States. This initiative will utilize a populomics approach, i.e., examination of health determinants across multiple scales of influence (e.g. molecular, cellular, physiological, lifestyle/behavioral, household, neighborhood, environmental, cultural, and sociopolitical) using multi-disciplinary methods to investigate the web of influences impacting the health, quality of life, and survival of adults living with HIV. This NOFO is limited to institutions who were funded under RFA-HL-19-008 and will fund up to 13 Clinical Research Sites (CRS) for the MWCCS. This NOFO runs in parallel with two companion U01 NOFOs: RFA-HL-26-010 (Limited Competition: Data Analysis and Sharing Center (DASC) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trials Not Allowed)) and RFA-HL-26-011 (Leadership and Coordination Center (LACC) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trials Not Allowed)).

## Questions people ask

### Is RFA-HL-26-009 still open?

No. It closed on May 2, 2025.

### Who can apply for Limited Competition: Clinical Research Sites (CRS) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from colleges and universities. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Limited Competition: Clinical Research Sites (CRS) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trial Not Allowed)?

Closed May 2, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $2.4 million each.

### Who has been funded under RFA-HL-26-009?

NIH RePORTER lists 13 projects funded under RFA-HL-26-009 in fiscal 2026, at 13 institutions. The most were at University of California, San Francisco, SUNY Downstate Medical Center, University of Alabama at Birmingham.

### Who has won Oral Diseases and Disorders Research grants before?

The largest recipients over five fiscal years were Regents of the University of Michigan, The Regents of the University of California, San Francisco, University of Southern California. The program made 2,263 awards worth $1.9 billion in that time.